By Iain Gilbert
Date: Thursday 10 Sep 2026
(Sharecast News) - Drugmaker GSK said on Thursday that Japan's Ministry of Health, Labour and Welfare has approved a prefilled syringe version of its shingles vaccine Shingrix, offering a simpler, ready‑to‑use presentation for healthcare professionals.
GSK said the vaccine was previously supplied in two separate vials that required manual mixing before...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news